Arcus Biosciences, Inc.

RCUS

N/A

NYSEBiotechnology🇺🇸North America627 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Jun 15, 2026

25w

Drug Pipeline

Drug Name	Phase	Indication	Designations
Casdatifan	Phase 3	Metastatic Clear Cell Renal Cell Carcinoma	-
Placebo	Phase 3	Metastatic Pancreatic Ductal Adenocarcinoma	-
Domvanalimab	Phase 3	Advanced Upper Gastrointestinal Tract Adenocarcinoma	-
Zimberelimab	Phase 2	Non Small Cell Lung Cancer	-
Quemliclustat	Phase 2	Gastrointestinal Tract Malignancies	-
AB680	Phase 2	Metastatic Colorectal Cancer	-
Etrumadenant	Phase 2	Prostatic Neoplasms, Castration-Resistant	-

Catalyst Timeline

1 upcoming, 0 past

⭐Phase 3Next

June 2026~Domvanalimab

Primary completion for Domvanalimab trial (NCT05568095) in Advanced Upper Gastrointestinal Tract Adenocarcinoma

Regulatory Approvals

RCUS News